• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

2000 - 2005年美国耐药感染住院情况的增长及地理差异

Growth and geographic variation in hospitalizations with resistant infections, United States, 2000-2005.

作者信息

Zilberberg Marya D, Shorr Andrew F, Kollef Marin H

机构信息

EviMed Research Group, LLC, Goshen, Massachussetts 01032, USA.

出版信息

Emerg Infect Dis. 2008 Nov;14(11):1756-8. doi: 10.3201/eid1411.080337.

DOI:10.3201/eid1411.080337
PMID:18976563
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2630735/
Abstract

From 2000 through 2005, hospitalizations with resistant infections (methicillin-resistant Staphylococcus aureus, Clostridium difficile-associated disease, vancomycin-resistant enterococcus, Pseudomonas aeruginosa, and Candida infection) nearly doubled, from 499,702 to 947,393. Regional variations noted in the aggregate and by individual infection may help clarify modifiable risk factors driving these infections.

摘要

从2000年到2005年，耐药感染（耐甲氧西林金黄色葡萄球菌、艰难梭菌相关疾病、耐万古霉素肠球菌、铜绿假单胞菌和念珠菌感染）导致的住院人数几乎翻了一番，从499,702人增至947,393人。总体以及个别感染方面存在的地区差异可能有助于明确导致这些感染的可改变风险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2953/2630735/664f66f485f5/08-0337-F.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2953/2630735/664f66f485f5/08-0337-F.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2953/2630735/664f66f485f5/08-0337-F.jpg

相似文献

1
Growth and geographic variation in hospitalizations with resistant infections, United States, 2000-2005.2000 - 2005年美国耐药感染住院情况的增长及地理差异
Emerg Infect Dis. 2008 Nov;14(11):1756-8. doi: 10.3201/eid1411.080337.
2
Multihospital surveillance of nosocomial methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococcus, and Clostridium difficile: analysis of a 4-year data-sharing project, 1999-2002.多医院耐甲氧西林金黄色葡萄球菌、耐万古霉素肠球菌和艰难梭菌的监测：1999 - 2002年一项为期4年的数据共享项目分析
Am J Infect Control. 2006 Sep;34(7):458-64. doi: 10.1016/j.ajic.2005.08.010.
3
Superbugs in the coming new decade; multidrug resistance and prospects for treatment of Staphylococcus aureus, Enterococcus spp. and Pseudomonas aeruginosa in 2010.未来十年的超级细菌；2010年金黄色葡萄球菌、肠球菌属和铜绿假单胞菌的多重耐药性及治疗前景
Curr Opin Microbiol. 2007 Oct;10(5):436-40. doi: 10.1016/j.mib.2007.07.004. Epub 2007 Aug 30.
4
[Nosocomial infections. Some aspects].[医院感染。若干方面]
Acta Med Port. 1993 Mar-Apr;6(3-4):135-40.
5
[Control of vancomycin resistant enterococcus and methicillin resistant staphylococcus aureus bacteria gaining every day].[对万古霉素耐药肠球菌和耐甲氧西林金黄色葡萄球菌的控制日益加强]
Perspect Infirm. 2003 Sep-Oct;1(1):25-6.
6
Infection acquisition following intensive care unit room privatization.重症监护病房病房私有化后的感染获得情况。
Arch Intern Med. 2011 Jan 10;171(1):32-8. doi: 10.1001/archinternmed.2010.469.
7
Antibiotic-resistant bloodstream infections in hospitalized patients: specific risk factors in a high-risk population?住院患者的耐抗生素血流感染：高危人群中的特定风险因素？
Infection. 2005 Oct;33(5-6):320-6. doi: 10.1007/s15010-005-5066-4.
8
Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: Position statement from the Joint SHEA and APIC Task Force.关于使用主动监测培养法筛查耐甲氧西林金黄色葡萄球菌和耐万古霉素肠球菌的立法授权：美国医疗保健流行病学学会（SHEA）与美国感染控制与流行病学专业人员协会（APIC）联合特别工作组的立场声明
Am J Infect Control. 2007 Mar;35(2):73-85. doi: 10.1016/j.ajic.2007.01.001.
9
Clostridium difficile and vancomycin-resistant enterococcus: the new nosocomial alliance.艰难梭菌与耐万古霉素肠球菌：新的医院内联盟。
Am J Gastroenterol. 2000 Dec;95(12):3513-5. doi: 10.1111/j.1572-0241.2000.03291.x.
10
Implementing guidelines for the control and prevention of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: how valid are international comparisons of success?实施耐甲氧西林金黄色葡萄球菌和耐万古霉素肠球菌的控制与预防指南：成功的国际比较有多有效？
J Hosp Infect. 2006 Feb;62(2):133-5. doi: 10.1016/j.jhin.2005.09.011. Epub 2005 Dec 5.

引用本文的文献

1
The Prevalence and Molecular Biology of Isolated from Healthy and Diseased Equine Eyes in Egypt.从埃及健康和患病马眼中分离出的[具体物质未给出]的患病率及分子生物学
Antibiotics (Basel). 2022 Feb 10;11(2):221. doi: 10.3390/antibiotics11020221.
2
IL-17-producing γδ T cells protect against Clostridium difficile infection.IL-17 产生的 γδ T 细胞可预防艰难梭菌感染。
J Clin Invest. 2020 May 1;130(5):2377-2390. doi: 10.1172/JCI127242.
3
Comparing the efficacy and safety of faecal microbiota transplantation with bezlotoxumab in reducing the risk of recurrent infections: a systematic review and Bayesian network meta-analysis of randomised controlled trials.

本文引用的文献

1
Increase in adult Clostridium difficile-related hospitalizations and case-fatality rate, United States, 2000-2005.2000 - 2005年美国成人艰难梭菌相关住院率及病死率上升情况
Emerg Infect Dis. 2008 Jun;14(6):929-31. doi: 10.3201/eid1406.071447.
2
Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005.1999 - 2005年美国耐甲氧西林金黄色葡萄球菌导致的住院治疗和死亡情况
Emerg Infect Dis. 2007 Dec;13(12):1840-6. doi: 10.3201/eid1312.070629.
3
Vancomycin-resistant Staphylococcus aureus in the United States, 2002-2006.
比较粪便微生物群移植与贝佐妥单抗在降低复发性感染风险方面的疗效和安全性：一项随机对照试验的系统评价和贝叶斯网络荟萃分析。
BMJ Open. 2019 Nov 7;9(11):e031145. doi: 10.1136/bmjopen-2019-031145.
4
Burden of hospitalizations over time with invasive aspergillosis in the United States, 2004-2013.2004-2013 年美国侵袭性曲霉菌病住院负担的时间变化。
BMC Public Health. 2019 May 17;19(1):591. doi: 10.1186/s12889-019-6932-9.
5
Modeling Clostridium difficile in a hospital setting: control and admissions of colonized and symptomatic patients.医院环境中艰难梭菌的建模：定植和有症状患者的控制与入院情况
Theor Biol Med Model. 2019 Jan 31;16(1):2. doi: 10.1186/s12976-019-0098-0.
6
Epidemiological and genomic characterization of community-acquired Clostridium difficile infections.社区获得性艰难梭菌感染的流行病学和基因组特征。
BMC Infect Dis. 2018 Aug 31;18(1):443. doi: 10.1186/s12879-018-3337-9.
7
Antibiotic Resistance Rates by Geographic Region Among Ocular Pathogens Collected During the ARMOR Surveillance Study.ARMOR监测研究期间收集的眼部病原体的地理区域抗生素耐药率
Ophthalmol Ther. 2018 Dec;7(2):417-429. doi: 10.1007/s40123-018-0141-y. Epub 2018 Aug 9.
8
Antifungal Activity of SCY-078 and Standard Antifungal Agents against 178 Clinical Isolates of Resistant and Susceptible Candida Species.SCY-078 与标准抗真菌药物对 178 株耐药和敏感念珠菌临床分离株的抗真菌活性。
Antimicrob Agents Chemother. 2017 Oct 24;61(11). doi: 10.1128/AAC.01102-17. Print 2017 Nov.
9
Colonization With Vancomycin-Resistant Enterococci and Risk for Bloodstream Infection Among Patients With Malignancy: A Systematic Review and Meta-Analysis.耐万古霉素肠球菌定植与恶性肿瘤患者血流感染风险：一项系统评价和荟萃分析
Open Forum Infect Dis. 2016 Dec 7;4(1):ofw246. doi: 10.1093/ofid/ofw246. eCollection 2017 Winter.
10
Comparative Evaluation of the BD Phoenix Yeast ID Panel and Remel RapID Yeast Plus System for Yeast Identification.BD Phoenix酵母鉴定板与Remel RapID Yeast Plus系统用于酵母鉴定的比较评估
Can J Infect Dis Med Microbiol. 2016;2016:4094932. doi: 10.1155/2016/4094932. Epub 2016 Apr 14.
2002 - 2006年美国耐万古霉素金黄色葡萄球菌
Clin Infect Dis. 2008 Mar 1;46(5):668-74. doi: 10.1086/527392.
4
Clostridium difficile: emergence of hypervirulence and fluoroquinolone resistance.艰难梭菌：高毒力和氟喹诺酮耐药性的出现
Infection. 2007 Oct;35(5):300-7. doi: 10.1007/s15010-007-6113-0. Epub 2007 Sep 20.
5
Different trends of MRSA and VRE in a German hospital, 1999-2005.1999 - 2005年德国一家医院耐甲氧西林金黄色葡萄球菌（MRSA）和耐万古霉素肠球菌（VRE）的不同趋势
Infection. 2007 Jun;35(4):245-9. doi: 10.1007/s15010-007-6234-5. Epub 2007 Jul 23.
6
Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05.2001年至2005年期间，非万古霉素中介金黄色葡萄球菌（VISA）、对万古霉素敏感的临床耐甲氧西林金黄色葡萄球菌（MRSA）血源分离株中万古霉素最低抑菌浓度（MIC）的缓慢上升。
J Antimicrob Chemother. 2007 Oct;60(4):788-94. doi: 10.1093/jac/dkm258. Epub 2007 Jul 10.
7
Methicillin-resistant S. aureus infections among patients in the emergency department.急诊科患者中的耐甲氧西林金黄色葡萄球菌感染
N Engl J Med. 2006 Aug 17;355(7):666-74. doi: 10.1056/NEJMoa055356.
8
Morbidity and cost burden of methicillin-resistant Staphylococcus aureus in early onset ventilator-associated pneumonia.早发性呼吸机相关性肺炎中耐甲氧西林金黄色葡萄球菌的发病率和成本负担
Crit Care. 2006;10(3):R97. doi: 10.1186/cc4934. Epub 2006 Jun 29.
9
Epidemiology of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus in a rural state.某乡村州耐甲氧西林金黄色葡萄球菌和耐万古霉素肠球菌的流行病学
Infect Control Hosp Epidemiol. 2006 Mar;27(3):252-6. doi: 10.1086/501537. Epub 2006 Feb 28.
10
The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs.抗菌药物耐药性与患者预后之间的关系：死亡率、住院时间和医疗费用。
Clin Infect Dis. 2006 Jan 15;42 Suppl 2:S82-9. doi: 10.1086/499406.